MedTrace Logo

A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

NCT06772532 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-13

No results posted yet for this study

Summary

The main objective of this trial is to investigate relative bioavailability of BI 456906 formulation B and BI 456906 formulation C vs. BI 456906 formulation A.

Conditions

  • Healthy

Interventions

COMBINATION_PRODUCT

BI 456906 - Formulation A

Formulation A

DRUG

BI 456906 - Formulation B

Formulation B

DRUG

BI 456906 - Formulation C

Formulation C

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2025-05-29
Completion
2025-06-10
FDA Drug
Yes

Countries

  • Germany

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06772532 on ClinicalTrials.gov